Literature DB >> 23624031

Changes in the PCOS phenotype with age.

Ming-I Hsu1.   

Abstract

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder of reproductive-age women. The diagnosis of PCOS is mainly based on the following three components: (1) hyperandrogenism, (2) oligo-amenorrhea, and (3) the observation of polycystic ovaries on a sonogram. The comorbidities may include insulin resistance, type II diabetes mellitus, hypertension and cardiovascular disease. Importantly, the diagnostic criteria and complications related to PCOS are age-dependent. Androgen production in women may decrease because of ovarian aging or decreased production by the adrenal glands over time. The prevalence of hirsutism and acne decreases with age. Ovarian volume and follicle number also decrease with age, with the age-related decrease in follicle number seemingly greater than that of ovarian volume. Aging may also be associated with increased risk of insulin resistance and metabolic disturbances. Therefore, these age-related changes may affect the observed incidence and complications of PCOS. In adolescent patients, the criteria described above pose particular diagnostic problems because the characteristics of normal puberty often overlap with the signs and symptoms of PCOS. Hyperandrogenism and chronic anovulation are the primary disturbances in younger women with PCOS; whereas, obesity, insulin resistance, and metabolic disturbances are predominant in older women with PCOS. The deterioration of insulin resistance during the reproductive life of women with PCOS appears to be mainly attributable to the increase in obesity. Therefore, if body weight could be controlled properly, younger hyperandrogenic PCOS women might reduce their risk of insulin resistance and metabolic disturbances later in life.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23624031     DOI: 10.1016/j.steroids.2013.04.005

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  25 in total

1.  Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.

Authors:  Uche Ezeh; Andy Huang; Melanie Landay; Ricardo Azziz
Journal:  J Womens Health (Larchmt)       Date:  2018-06-07       Impact factor: 2.681

2.  Depression Over the Lifespan in a Population-Based Cohort of Women With Polycystic Ovary Syndrome: Longitudinal Analysis.

Authors:  Eleni A Greenwood; Kristine Yaffe; Melissa F Wellons; Marcelle I Cedars; Heather G Huddleston
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

3.  Low Serum 25-Hydroxyvitamin D Levels Are Associated With Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study.

Authors:  Chang Shan; Yu-Chen Zhu; Jie Yu; Yi Zhang; Yu-Ying Wang; Nan Lu; Jie Cai; Wei Liu; Tao Tao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-02       Impact factor: 6.055

4.  Increasing serum 25-hydroxyvitamin D is associated with reduced odds of long menstrual cycles in a cross-sectional study of African American women.

Authors:  Anne Marie Z Jukic; Kristen Upson; Quaker E Harmon; Donna D Baird
Journal:  Fertil Steril       Date:  2016-03-18       Impact factor: 7.329

5.  Reproductive Deficits Induced by Prenatal Antimüllerian Hormone Exposure Require Androgen Receptor in Kisspeptin Cells.

Authors:  Emily V Ho; Chengxian Shi; Jessica Cassin; Michelle Y He; Ryan D Nguyen; Genevieve E Ryan; Karen J Tonsfeldt; Pamela L Mellon
Journal:  Endocrinology       Date:  2021-12-01       Impact factor: 5.051

Review 6.  Clinical characteristics in Taiwanese women with polycystic ovary syndrome.

Authors:  Ming-I Hsu
Journal:  Clin Exp Reprod Med       Date:  2015-09-30

7.  The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment.

Authors:  Carrie C Dennett; Judy Simon
Journal:  Diabetes Spectr       Date:  2015-05

8.  Sex- and age-specific reference intervals for diagnostic ratios reflecting relative activity of steroidogenic enzymes and pathways in adults.

Authors:  Valentin Rousson; Daniel Ackermann; Belen Ponte; Menno Pruijm; Idris Guessous; Claudia H d'Uscio; Georg Ehret; Geneviève Escher; Antoinette Pechère-Bertschi; Michael Groessl; Pierre-Yves Martin; Michel Burnier; Bernhard Dick; Murielle Bochud; Bruno Vogt; Nasser A Dhayat
Journal:  PLoS One       Date:  2021-07-08       Impact factor: 3.240

Review 9.  Polycystic ovary syndrome: clinical implication in perimenopause.

Authors:  Monika Lenart-Lipińska; Beata Matyjaszek-Matuszek; Ewa Woźniakowska; Janusz Solski; Jerzy S Tarach; Tomasz Paszkowski
Journal:  Prz Menopauzalny       Date:  2014-12-30

10.  The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.

Authors:  Fahimeh Ramezani Tehrani; Homeira Rashidi; Mahnaz Bahri Khomami; Maryam Tohidi; Fereidoun Azizi
Journal:  Reprod Biol Endocrinol       Date:  2014-09-16       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.